Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades Globus Medical to Neutral

BTIG Downgrades Globus Medical to Neutral

BTIG analyst Ryan Zimmerman downgrades Globus Medical (NYSE:GMED) from Buy to Neutral.

byBenzinga Newsdesk

February 10, 2023

1 minute read

BTIG analyst Ryan Zimmerman downgrades Globus Medical (NYSE:GMED) from Buy to Neutral.

Vornado Realty Q4 EPS $0.72 Down From $0.81 YoY, Sales $446.94M Miss $455.78M Estimate

By Happy Mohamed

February 13, 5:22 PM

Vornado Realty (NYSE:VNO) reported quarterly earnings of $0.72 per share. This is a 11.11 percent decrease over earnings of $0.81 per share from the same period last year. The company reported quarterly sales of $446.94

VNO

INmune Bio Inc. Raises ~$4.8M In Gross Proceeds Through Registered Direct Offering With Officers, Employees And Directors Purchasing ~20% Of The Offering

By Benzinga Newsdesk

April 22, 8:06 AM

INmune Bio, Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announced today that

INMB